form423b3.htm
Supplement No. 1
Dated June 9, 2014
(To Prospectus dated April 29, 2014)
Rule 424(b)(3)
Registration No. 333- 189337 

DELMAR PHARMACEUTICALS, INC.

This prospectus supplement (“Supplement”) modifies, supersedes and supplements information contained in, and should be read in conjunction with, that certain prospectus, dated April 29, 2014 (“Prospectus”), of DelMar Pharmaceuticals, Inc. This Supplement is not complete without, and may not be delivered or used except in connection with, the original Prospectus.

The information included in this Supplement modifies and supersedes, in part, the information in the Prospectus. Any information that is modified or superseded in the Prospectus shall not be deemed to constitute a part of the Prospectus, except as modified or superseded by this Supplement.
 
We may amend or supplement the Prospectus from time to time by filing amendments or supplements as required. You should read the entire Prospectus and any amendments or supplements carefully before you make an investment decision.

See “Risk Factors” beginning on page 2 of the prospectus dated April 29, 2014, for risk factors and information you should consider before you purchase shares.

Recent Developments

On June 6, 2014, pursuant to an election to exercise warrants agreement the Company reduced the warrant exercise price from $0.80 to $0.65 per share on Investor Warrants to purchase 3,652,211 shares of the Company’s common stock and in accordance with the agreement, the holders of such Investor Warrants exercised the Investor Warrants for cash at the foregoing reduced exercise price.

The selling stockholders who exercised their Investor Warrants at the reduced exercise price of $0.65 pursuant to the foregoing consisted of the following:

   
Number of Investor Warrants Exercised
   
Number of Investor Warrants Remaining
 
             
Howard K. Fuguet
    1,000,000       0  
Justin K. McCormick
    125,000       0  
Robert Mike Newsome
    625,000       0  
John C. Ramsay
    183,750       0  
Renald & Catherine C. Anelle
    118,461       81,539  
William R. Lefever
    287,000       0  
DCG & T TTEE FBO Howard K. Fuguet IRA
    250,000       0  
DCG & T TTEE FBO David King IRA
    83,750       0  
Lawrence Grossbard 
    38,000       210,125  
Richard Grossbard
    93,750       93,750  
William C. Stone & Megan N. Williams
    85,000       25,000  
DCG & T TTEE FBO Raymond Coppede R/O IRA
    125,000       125,000  
William C. & Debra B. Purdon
    45,000       0  
DCG & T TTEE FBO William C. Stone SEP IRA
    97,500       0  
Ralph D. Bias
    125,000       0  
James W. Fugate
    120,000       5,000  
Joseph B. Byrum
    250,000       0